LeonaBio, Inc. - Common Stock, $0.0001 par value per share (LONA)

CUSIP: 04746L203

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
3,988,895
Total 13F shares
6,205,300
Share change
+3,906,117
Total reported value
$46,703,177
Price per share
$7.57
Number of holders
42
Value change
+$29,686,872
Number of buys
20
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 04746L203?
CUSIP 04746L203 identifies LONA - LeonaBio, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of LONA - LeonaBio, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
PERCEPTIVE ADVISORS LLC
3/4/5 13F
Director, 10%+ Owner · Company
14%
from 13F
8,292,785
mixed-class rows
$17,718,931 23 Dec 2025
BML Capital Management, LLC
13F
Company
8.1%
323,066
$1,337,493 30 Sep 2025
13F
VANGUARD GROUP INC
13F
Company
3.9%
153,789
$636,687 30 Sep 2025
13F
Propel Bio Management, LLC
13F
Company
3.7%
149,279
$618,015 30 Sep 2025
13F
Simplify Asset Management Inc.
13F
Company
3.7%
149,279
$618,015 30 Sep 2025
13F
Baselake Partners, LP
13D/G
1.9%
75,789
$573,723 -$921,208 31 Dec 2025
Focus Partners Wealth
13F
Company
0.21%
8,415
$558,083 30 Sep 2025
13F
Hans Moebius
3/4/5
Chief Medical Officer
class O/S missing
91,482
$266,213 04 Jan 2024
TANG CAPITAL MANAGEMENT LLC
13F
Company
1.5%
59,998
$248,392 30 Sep 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1.3%
51,924
$214,965 30 Sep 2025
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
1%
40,186
$165,000 30 Sep 2025
13F
Pathstone Holdings, LLC
13F
Company
0.97%
38,606
$159,829 30 Sep 2025
13F
BlackRock, Inc.
13F
Company
0.94%
37,643
$155,841 30 Sep 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.85%
33,987
$140,706 30 Sep 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.82%
32,614
$135,022 30 Sep 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.77%
30,593
$126,690 30 Sep 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.53%
20,986
$86,882 30 Sep 2025
13F
Steven Michael Oliveira
13D/G
Oliveira Steven Michael
4.1%
161,218
$69,324 -$788,375 01 Oct 2025
TWO SIGMA ADVISERS, LP
13F
Company
0.37%
14,860
$61,520 30 Sep 2025
13F
Andrew Gengos
3/4/5
CFO and Chief Business Officer
mixed-class rows
377,532
mixed-class rows
$55,203 03 Sep 2024
STATE STREET CORP
13F
Company
0.27%
10,737
$44,451 30 Sep 2025
13F
Laird Norton Wetherby Trust Company, LLC
13F
Company
0.25%
10,088
$41,764 30 Sep 2025
13F
OSAIC HOLDINGS, INC.
13F
Company
mixed-class rows
8,010
mixed-class rows
$29,961 30 Sep 2025
13F
Rachel Lenington
3/4/5
COO and CDO
mixed-class rows
320,870
mixed-class rows
$11,812 03 Sep 2024
Tower Research Capital LLC (TRC)
13F
Company
0.02%
638
$2,641 30 Sep 2025
13F
MORGAN STANLEY
13F
Company
0.01%
510
$2,112 30 Sep 2025
13F
American Capital Advisory, LLC
13F
Company
0.01%
200
$828 30 Sep 2025
13F
ROTHSCHILD INVESTMENT LLC
13F
Company
0%
150
$621 30 Sep 2025
13F
UBS Group AG
13F
Company
0%
144
$596 30 Sep 2025
13F
Global Retirement Partners, LLC
13F
Company
mixed-class rows
104
mixed-class rows
$430 30 Sep 2025
13F
McIlrath & Eck, LLC
13F
Company
0%
82
$339 30 Sep 2025
13F
US BANCORP \DE\
13F
Company
0%
81
$335 30 Sep 2025
13F
JONES FINANCIAL COMPANIES LLLP
13F
Company
0%
33
$127 30 Sep 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
23
$95 30 Sep 2025
13F
SBI Securities Co., Ltd.
13F
Company
0%
22
$91 30 Sep 2025
13F
JPMORGAN CHASE & CO
13F
Company
0%
12
$50 30 Sep 2025
13F
BARCLAYS PLC
13F
Company
0%
7
$29 30 Sep 2025
13F
CITIGROUP INC
13F
Company
0%
1
$4 30 Sep 2025
13F
Glenna Mileson
3/4/5
Chief Financial Officer
class O/S missing
150,000
19 Jan 2023
Tadataka Yamada
3/4/5
Director
class O/S missing
13,871
28 May 2021

Institutional Holders of LeonaBio, Inc. - Common Stock, $0.0001 par value per share (LONA) as of Q4 2025

As of 31 Dec 2025, LeonaBio, Inc. - Common Stock, $0.0001 par value per share (LONA) was held by 42 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,205,300 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, ACORN CAPITAL ADVISORS, LLC, NEA Management Company, LLC, TCG Crossover Management, LLC, Commodore Capital LP, Kalehua Capital Management LLC, Spruce Street Capital LP, ADAR1 Capital Management, LLC, MILLENNIUM MANAGEMENT LLC, and VANGUARD GROUP INC. This page lists 42 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
32
Q4 2025 holders
42
Holder diff
10
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .